Mogito Open Access Journal of Oncology & Cancer Studies (MJOCS)
At the Mogito Open Access Journal of Oncology and Cancer Studies (MJOCS), our editorial policy reflects an unwavering commitment to oncology excellence, clinical innovation, and the highest standards of scientific integrity. MJOCS follows a rigorous, peer-reviewed editorial framework that emphasizes ethical cancer research, open-access dissemination, and worldwide knowledge sharing.
MJOCS Editorial Policy – Excellence, Integrity & Global Oncology Impact
Our scope encompasses all aspects of modern oncology, including:
- Molecular diagnostics and cancer genomics
- Targeted therapies and immuno-oncology
- Cancer prevention, early detection, and screening
- Epidemiology, survivorship, and patient-centered care
- Translational research, clinical trials, and public health policy
Every article published in MJOCS is carefully reviewed to ensure it advances cancer science, improves patient outcomes, and informs clinical practice globally.
With guidance from our Editorial Board and international peer reviewers, MJOCS maintains a platform where transparency, credibility, and academic rigor drive the publication of impactful oncology research. Our mission is to foster equitable access to cancer knowledge, support innovative therapies, and promote better care worldwide.
We value the contributions of our editorial board members. As a token of appreciation, nominated editors enjoy the benefit of publishing their articles on our platform free of charge—while actively shaping the future of clinical research.
Mogito Open Access Journal of Oncology and Cancer Studies (MJOCS) – Scope & Editorial Guidelines
1. Scope of Content
MJOCS publishes high-quality, peer-reviewed research advancing oncology science, clinical practice, and translational cancer studies across all cancer types and specialties. We accept:
- Original research articles
- Systematic reviews and meta-analyses
- Clinical trials and translational studies
- Technical notes and innovations in oncology
- Case reports and case series
- Editorials, perspectives, and correspondence
Areas of interest include:
- Cancer biology, molecular oncology, and genetics
- Immunotherapy, targeted therapies, and oncology therapeutics
- Early detection, biomarkers, and diagnostic innovations
- Radiation, surgical, and medical oncology
- Cancer prevention, screening, and epidemiology
- Psychosocial oncology, palliative care, and survivorship
- Global oncology, health disparities, and policy
- Ethics, outcomes, and quality of cancer care
2. Peer Review Process
MJOCS implements a double-blind peer review system to ensure rigorous, unbiased evaluation. Each manuscript is reviewed by at least two independent experts based on:
- Scientific validity and methodological rigor
- Relevance to oncology and translational impact
- Originality and research contribution
- Clinical applicability and patient care significance
- Clarity, structure, and quality of writing
Conflicting reviews may involve a third reviewer or senior editor. Authors are expected to revise per feedback. Final publication decisions remain fair, timely, and confidential.
3. Authorship & Contributions
MJOCS follows ICMJE authorship guidelines. Authors must contribute significantly to:
- Study design or conceptualization
- Data acquisition, analysis, or interpretation
- Drafting or revising the manuscript
- Final approval of the published version
- Accountability for the integrity of the work
All contributions must be declared at submission. Guest or ghost authorship is strictly prohibited.
4. Ethical Standards
MJOCS adheres to COPE guidelines. Submissions must include:
- Institutional ethics approval for human or animal studies
- Informed consent for identifiable patient data or images
- Disclosure of conflicts of interest
- Assurance of originality (no plagiarism or data fabrication)
Violations may lead to retraction or institutional notification.
5. Open Access Policy
MJOCS is fully open access under a Creative Commons Attribution License (CC BY 4.0), enabling free distribution, sharing, and reuse with proper citation.
6. Data Transparency & Availability
Authors are encouraged to include data availability statements and share datasets supporting their research, except where privacy or legal restrictions apply.
7. Corrections, Retractions & Expressions of Concern
To maintain scientific integrity, MJOCS publishes:
- Corrections for minor factual errors
- Retractions for confirmed ethical or scientific misconduct
- Expressions of Concern for unresolved issues
All notices are clearly linked to the original article.
8. Editorial Independence
MJOCS ensures full editorial independence. Decisions are free from commercial, institutional, or sponsor influence. Editors and reviewers are selected for expertise, objectivity, and integrity. Advertising that compromises editorial judgment is not permitted.
9. Appeals & Complaints
Authors may appeal editorial decisions with documented reasoning. Appeals are reviewed by a senior editorial committee. Ethical concerns or complaints are handled confidentially according to COPE guidelines.
10. Indexing & Archiving
MJOCS is actively pursuing indexing in:
All published content is digitally archived to ensure long-term access and citation reliability.
Contact
For editorial policy inquiries:
📧 editors_mjocs@mogitojournals.org
🌐 www.mogitojournals.org
To celebrate the launch of MJCM, the first 10 accepted manuscripts will be published free of charge.
Submit now and enjoy open access publishing at no cost.
Ready to Publish Your Research
We’re here to guide you through every step of your publishing journey—from submission to global reach..
Let’s advance knowledge and discovery—together.
When connected with us, you aren’t growing your business alone. We have your back and put in our best to contribute to the growth of your entire team and organization. So, if you are “When you publish with us, you’re not navigating the process alone. Our editorial team is committed to supporting you through peer review, publication, and global dissemination. If you’re looking for the right platform to share your research, enhance visibility, and make a meaningful impact—Mogito is here for you.”